Ligands for imaging cardiac innervation
    6.
    发明授权
    Ligands for imaging cardiac innervation 有权
    用于成像心脏神经支配的配体

    公开(公告)号:US08491868B2

    公开(公告)日:2013-07-23

    申请号:US12448575

    申请日:2007-12-21

    摘要: Novel compounds that find use as imaging agents within nuclear medicine applications (PET imaging) for imaging of cardiac innervation are disclosed. These PET based radiotracers may exhibit increased stability, decreased NE release (thereby reducing side effects), improved quantitative data, and/or high affinity for VMAT over prior radiotracers. Methods of using the compounds to image cardiac innervation are also provided. In some instances the compounds are developed by derivatizing certain compounds with 18F in a variety of positions: aryl, alkyl, a keto, benzylic, beta-alkylethers, gamma-propylalkylethers and beta-proplylalkylethers. Alternatively or additionally, a methyl group a is added to the amine, and/or the catechol functionality is either eliminated or masked as a way of making these compounds more stable.

    摘要翻译: 公开了用于心脏神经支配成像的核医学应用(PET成像)中用作成像剂的新型化合物。 这些基于PET的放射性示踪剂可能表现出增加的稳定性,减少NE释放(从而减少副作用),改进的定量数据,和/或对先前的放射性示踪剂对VMAT的高亲和力。 还提供了使用化合物成像心脏神经支配的方法。 在某些情况下,化合物通过在各种位置上衍生化某些化合物而形成:芳基,烷基,酮基,苄基,β-烷基醚,γ-丙基烷基醚和β-丙基烷基醚。 或者或另外,将甲基a加入到胺中,和/或儿茶酚官能团被消除或掩蔽,作为使这些化合物更稳定的方式。

    PREPARATION OF RADIOLABELLED HALOAROMATICS VIA POLYMER-BOUND INTERMEDIATES
    7.
    发明申请
    PREPARATION OF RADIOLABELLED HALOAROMATICS VIA POLYMER-BOUND INTERMEDIATES 审中-公开
    通过聚合物中间体制备无定形血红蛋白

    公开(公告)号:US20100274052A1

    公开(公告)日:2010-10-28

    申请号:US12702009

    申请日:2010-02-08

    IPC分类号: C07C279/02

    摘要: According to a first aspect of the invention, a process is disclosed for the preparation of radiolabelled haloaromatic compounds. According to a second aspect of the invention, intermediate precursor insoluble polymer compounds used in the preparation of the radiolabelled haloaromatics are disclosed, as well as processes for the preparation of the intermediate precursor insoluble polymer compounds.

    摘要翻译: 根据本发明的第一方面,公开了制备放射性标记的卤代芳族化合物的方法。 根据本发明的第二方面,公开了用于制备放射性标记的卤代芳烃的中间体前体不溶性聚合物化合物,以及制备中间体前体不溶性聚合物化合物的方法。

    Imaging agents
    8.
    发明授权
    Imaging agents 有权
    成像剂

    公开(公告)号:US07534418B2

    公开(公告)日:2009-05-19

    申请号:US11009923

    申请日:2004-12-10

    IPC分类号: A61K51/00 A61M36/14

    摘要: The present invention provides novel compounds that find use as imaging agents within nuclear medicine applications (e.g., PET imaging and SPECT imaging). The present invention also provides imaging compositions for use within nuclear medicine applications. Additionally, the present invention provides methods of imaging.

    摘要翻译: 本发明提供了在核医学应用(例如PET成像和SPECT成像)中用作成像剂的新型化合物。 本发明还提供了用于核医学应用中的成像组合物。 另外,本发明提供了成像方法。

    Preparation of radiolabelled haloaromatics via polymer-bound intermediates
    10.
    发明申请
    Preparation of radiolabelled haloaromatics via polymer-bound intermediates 有权
    通过聚合物结合的中间体制备放射性标记的卤代芳族化合物

    公开(公告)号:US20030012730A1

    公开(公告)日:2003-01-16

    申请号:US10224261

    申请日:2002-08-20

    IPC分类号: A61K051/00 C07C017/093

    摘要: According to a first aspect of the invention, a process is disclosed for the preparation of radiolabelled haloaromatic compounds. According to a second aspect of the invention, intermediate precursor insoluble polymer compounds used in the preparation of the radiolabelled haloaromatics are disclosed, as well as processes for the preparation of the intermediate precursor insoluble polymer compounds.

    摘要翻译: 根据本发明的第一方面,公开了制备放射性标记的卤代芳族化合物的方法。 根据本发明的第二方面,公开了用于制备放射性标记的卤代芳烃的中间体前体不溶性聚合物化合物,以及制备中间体前体不溶性聚合物化合物的方法。